WO2004058815A3 - Proteine associee aux centrosomes et ses applications - Google Patents

Proteine associee aux centrosomes et ses applications Download PDF

Info

Publication number
WO2004058815A3
WO2004058815A3 PCT/FR2003/003895 FR0303895W WO2004058815A3 WO 2004058815 A3 WO2004058815 A3 WO 2004058815A3 FR 0303895 W FR0303895 W FR 0303895W WO 2004058815 A3 WO2004058815 A3 WO 2004058815A3
Authority
WO
WIPO (PCT)
Prior art keywords
centrosome
applications
protein
associated protein
polynucleotide
Prior art date
Application number
PCT/FR2003/003895
Other languages
English (en)
Other versions
WO2004058815A2 (fr
WO2004058815B1 (fr
Inventor
Dominique Giorgi
Sylvie Rouquier
Jean-Michel Saffin
Original Assignee
Centre Nat Rech Scient
Dominique Giorgi
Sylvie Rouquier
Jean-Michel Saffin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Dominique Giorgi, Sylvie Rouquier, Jean-Michel Saffin filed Critical Centre Nat Rech Scient
Priority to JP2004563311A priority Critical patent/JP4660200B2/ja
Priority to EP03813937A priority patent/EP1578792A2/fr
Priority to AU2003303464A priority patent/AU2003303464A1/en
Priority to US10/540,493 priority patent/US7402394B2/en
Priority to CA002511436A priority patent/CA2511436A1/fr
Publication of WO2004058815A2 publication Critical patent/WO2004058815A2/fr
Publication of WO2004058815A3 publication Critical patent/WO2004058815A3/fr
Publication of WO2004058815B1 publication Critical patent/WO2004058815B1/fr
Priority to US12/216,510 priority patent/US20090275024A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention est relative une nouvelle protéine associée aux centrosomes, au polynucléotide codant pour ladite protéine ainsi qu'aux applications de ladite protéine et dudit polynucléotide. La surexpression de la protéine selon l'invention entraîne des perturbations dans l'organisation du fuseau mitotique et induit des mitoses aberrantes et abortives.
PCT/FR2003/003895 2002-12-24 2003-12-24 Proteine associee aux centrosomes et ses applications WO2004058815A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2004563311A JP4660200B2 (ja) 2002-12-24 2003-12-24 中心体結合タンパク質およびその適用
EP03813937A EP1578792A2 (fr) 2002-12-24 2003-12-24 Nouvelle proteine associee aux centrosomes et ses applications
AU2003303464A AU2003303464A1 (en) 2002-12-24 2003-12-24 Centrosome-associated protein and applications thereof
US10/540,493 US7402394B2 (en) 2002-12-24 2003-12-24 Centrosome-associated protein and applications thereof
CA002511436A CA2511436A1 (fr) 2002-12-24 2003-12-24 Proteine associee aux centrosomes et ses applications
US12/216,510 US20090275024A1 (en) 2002-12-24 2008-07-07 Novel centrerosome-associated protein and applications thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0216648A FR2849039B1 (fr) 2002-12-24 2002-12-24 Nouvelle proteine associee aux centrosomes et ses applications
FR02/16648 2002-12-24

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/216,510 Division US20090275024A1 (en) 2002-12-24 2008-07-07 Novel centrerosome-associated protein and applications thereof

Publications (3)

Publication Number Publication Date
WO2004058815A2 WO2004058815A2 (fr) 2004-07-15
WO2004058815A3 true WO2004058815A3 (fr) 2005-03-17
WO2004058815B1 WO2004058815B1 (fr) 2005-05-06

Family

ID=32406499

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2003/003895 WO2004058815A2 (fr) 2002-12-24 2003-12-24 Proteine associee aux centrosomes et ses applications

Country Status (7)

Country Link
US (2) US7402394B2 (fr)
EP (1) EP1578792A2 (fr)
JP (1) JP4660200B2 (fr)
AU (1) AU2003303464A1 (fr)
CA (1) CA2511436A1 (fr)
FR (1) FR2849039B1 (fr)
WO (1) WO2004058815A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2789446A1 (fr) * 2010-02-12 2011-08-18 Oncomed Pharmaceuticals, Inc. Procedes d'identification et d'isolement de cellules exprimant un polypeptide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073801A2 (fr) * 1999-05-28 2000-12-07 Ludwig Institute For Cancer Research Antigenes associes au cancer du sein, de la prostate et de l'estomac et leur utilisation
WO2002070539A2 (fr) * 2001-03-05 2002-09-12 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073801A2 (fr) * 1999-05-28 2000-12-07 Ludwig Institute For Cancer Research Antigenes associes au cancer du sein, de la prostate et de l'estomac et leur utilisation
WO2002070539A2 (fr) * 2001-03-05 2002-09-12 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EM_HTG 18 December 2002 (2002-12-18), ADACHI, J. ET AL.: "Mus musculus adult male pituitary gland cDNA, RIKEN full-length enriched library, clone:5330427D05 product:weakly similar to CDNA: FLJ21159 FIS, CLONE CAS09969 [Homo sapiens], full insert sequence.", XP002307713, Database accession no. AK030527 *
DATABASE EM_HUM [online] 25 October 2001 (2001-10-25), WATERSTONE R.H.: "Homo sapiens BAC clone RP11-27G13 from 4, complete sequence", XP002252293, Database accession no. AC097467 *
DATABASE EM_HUM 29 September 2000 (2000-09-29), SUGANO S. ET AL.: "Homo sapiens cDNA: FLJ21159 fis, clone CAS09969", XP002288171, Database accession no. AK024812 *
DATABASE EMBL 5 November 2003 (2003-11-05), STRAUSBERG R.L. ET AL.: "Mus musculus RIKEN cDNA 5330427D05 gene, mRNA (cDNA clone IMAGE:30254438), partial cds.", XP002307714, Database accession no. BC061216 *
DOBIE K W ET AL: "Centromere proteins and chromosome inheritance: A complex affair", CURRENT OPINION IN GENETICS AND DEVELOPMENT 1999 UNITED KINGDOM, vol. 9, no. 2, 1999, pages 206 - 217, XP002288170, ISSN: 0959-437X *
RAFF JORDAN W: "Centrosomes and cancer: Lessons from a TACC", TRENDS IN CELL BIOLOGY, vol. 12, no. 5, May 2002 (2002-05-01), pages 222 - 225, XP002288169, ISSN: 0962-8924 *

Also Published As

Publication number Publication date
FR2849039A1 (fr) 2004-06-25
US7402394B2 (en) 2008-07-22
WO2004058815A2 (fr) 2004-07-15
JP2006526387A (ja) 2006-11-24
FR2849039B1 (fr) 2010-10-01
AU2003303464A1 (en) 2004-07-22
AU2003303464A8 (en) 2004-07-22
US20060216710A1 (en) 2006-09-28
WO2004058815B1 (fr) 2005-05-06
US20090275024A1 (en) 2009-11-05
EP1578792A2 (fr) 2005-09-28
CA2511436A1 (fr) 2004-07-15
JP4660200B2 (ja) 2011-03-30

Similar Documents

Publication Publication Date Title
AU2002341503A1 (en) Antimicrobial polypeptide from aspergillus niger
MXPA03006234A (es) Limpiador acido antimicrobiano para superficies duras.
AU2002351353A1 (en) Stabilizing polypeptides which have been exposed to urea
AU2002348720A1 (en) Location-based content protection
AU2003247895A1 (en) Improved skirt guided valve
AU2003254544A1 (en) Compositions comprising lactoferrin
AU2002246339A1 (en) Screw cap of synthetic resin
MXPA03007130A (es) Conjugados de peg de hgf-nk4.
AUPR279101A0 (en) Protein kinase signalling
AU2003262380A1 (en) Signaling assembly
AU2003206367A1 (en) Technical field of the invention
WO2004058815A3 (fr) Proteine associee aux centrosomes et ses applications
EG23393A (en) Production of olefins.
AU2003219569A1 (en) Antimicrobial peptide, its analogs and antimicrobial composition comprising them
WO2003057712A3 (fr) Lactoferrine humanisee et utilisations de celle-ci
MXPA03007646A (es) Plaguicida sinergico.
AU2001257282A1 (en) Association of protein kinase c zeta polymorphisms with diabetes
WO2004020466A8 (fr) Inhibiteurs de proteine tyrosine phosphatase
IT1316997B1 (it) Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
AU2003206963A1 (en) Absolute position encoder
AU2002367159A1 (en) Field of the invention
WO2003040297A3 (fr) Nouvelle proteine de la famille des defensines
AUPS301302A0 (en) Antimicrobial furanones
AUPR576201A0 (en) Antimicrobial furanones
AU2002360514A1 (en) hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
B Later publication of amended claims

Effective date: 20050216

WWE Wipo information: entry into national phase

Ref document number: 2004563311

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2511436

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2006216710

Country of ref document: US

Ref document number: 10540493

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2003813937

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003813937

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10540493

Country of ref document: US